# Listening to Australians with ovarian cancer: a cross-sectional survey investigating clinical trials awareness, information access and participation

**Authors:** Natalie Williams, Yeh Chen Lee, Hayley Russell, John Andrews, Won Sun Chen, Bridget Bradhurst

PMC · DOI: 10.1007/s00520-026-10586-1 · Supportive Care in Cancer · 2026-03-22

## TL;DR

This study surveyed Australian ovarian cancer patients to understand their awareness of clinical trials and their needs for better information resources.

## Contribution

The study provides insights into information access preferences and barriers for ovarian cancer patients, guiding the development of centralized clinical trial resources.

## Key findings

- Most respondents had moderate knowledge of clinical trials but recognized their importance.
- Over half of the respondents did not receive clinical trial information from healthcare providers.
- Preferred information delivery methods included email newsletters and online hubs.

## Abstract

To inform development of centralised, evidence-based clinical trials resources for Australians with ovarian cancer, a structured understanding of knowledge gaps and resource needs was essential. The study aimed to assist resource development by assessing awareness, information access, and participation in clinical trials of ovarian cancer patients.

A national, cross-sectional online survey among Australians with ovarian cancer was conducted between October and November 2024. Descriptive and inferential statistics along with qualitative content analyses were conducted. Associations were examined using Chi-Square and Fisher Exact tests.

Surveys from 272 respondents indicated moderate knowledge (\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\overline{x }$$\end{document}x¯ = 4.46/10, SD = 2.34) and a high perception of importance of clinical trials (\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\overline{x }$$\end{document}x¯ = 9.27/10, SD = 1.17). 56% of respondents reported not receiving clinical trials information and 44% had sought information themselves. Respondents preferred information by email newsletter (34%), through health professional discussions (20%) and accessing an online information hub (17%). Information access enablers included clinicians being knowledgeable about clinical trials, personalised discussions, and access to a centralised information source. Barriers included fragmented information across websites, use of complex medical language and competing responsibilities as caregivers. A qualitative analysis of open-ended responses (n = 96) revealed three core themes: ‘we need better solutions to help find information and participate in clinical trials’, ‘weighing up options’ in their decision to participate, and ‘we want to help improve outcomes for women in the future’.

Results from this study of Australians with ovarian cancer inform actionable change through development of evidence-based, tailored resources. Further solutions and evaluation of intervention effectiveness will continue through sector collaboration.

The online version contains supplementary material available at 10.1007/s00520-026-10586-1.

## Linked entities

- **Diseases:** ovarian cancer (MONDO:0005140)

## Full-text entities

- **Diseases:** brain fog (MESH:D005222), cognitive disturbance (MESH:D003072), Ovarian Cancer (MESH:D010051), anxiety (MESH:D001007), Cancer (MESH:D009369), grief and loss (MESH:D016388)
- **Chemicals:** Chemo (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13005823/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13005823/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC13005823/full.md

---
Source: https://tomesphere.com/paper/PMC13005823